Fifteen percent of

patients meeting GANT61 manufacturer previous ATS guidelines failed to meet revised criteria due to a lack of honeycombing on high-resolution computed tomography and the absence of a surgical lung biopsy. Patients failing to meet previous and revised diagnostic criteria for IPF were younger. CONCLUSION: The revised guidelines for the diagnosis of IPF classify a substantial proportion of patients differently than the previous guidelines.”
“Aim: Obesity has been implicated in the aetiology of myelogenous leukaemia and myelodysplasia (MDS). We hypothesised that altered secretion of adiponectin and resistin may underlie this association. We thus investigated the role of both total and high molecular weight (HMW) adiponectin and resistin in MDS.\n\nMethods: In a case-control study, we studied 101 cases with incident, histologically confirmed primary MDS and 101 controls matched on gender and age between 2004 and 2007. Total and HMW adiponectin, resistin, insulin-like growth factor-I (IGF-I) and

insulin-like growth factor binding protein (IGFBP-3) were determined.\n\nResults: Lower serum total or HMW adiponectin and/or resistin levels were independently associated with higher risk of MDS controlling for age, gender, BMI and serum levels of leptin, IGF-I and IGFBP-3 (p < 0.002). Although total and HMW adiponectin were both significantly inversely associated with MDS when Selleckchem Nutlin-3 modelled either in quartiles or continuously, HMW did not offer any substantial additional predictive value over total adiponectin (Odds ratio (OR) = 0.91 versus 0.93 for a 1 mu g/ml GM6001 Proteases inhibitor change, respectively). IGF-I was positively associated with MDS by bivariate analysis and both IGF-I and IGFBP-3 were higher in advanced MDS and higher risk stages, but were not significantly and independently associated with MDS.\n\nConclusion: Total and HMW adiponectin may have a protective role in MDS, whereas resistin levels may be decreased via a compensatory mechanism. (C) 2008 Elsevier Ltd. All rights reserved.”
“Gordon NM, Rudroff T, Enoka JA, Enoka RM. Handedness but not

dominance influences variability in endurance time for sustained, submaximal contractions. J Neurophysiol 108: 1501-1510, 2012. First published June 13, 2012; doi:10.1152/jn.01144.2011.-The purpose of this study was to compare endurance time and accompanying neuromuscular adjustments when left- and right-handed subjects used the dominant and nondominant arms to sustain submaximal contractions that required either force or position control. Ten left-handed and 10 right-handed healthy adults (21 +/- 5 yr) participated in the study. Each subject exerted a similar net torque about the elbow joint during the force and position tasks to achieve a target force of 20% maximal voluntary contraction (MVC) force (56 +/- 18 N). MVC force declined to a similar level immediately after task failure for left-and right-handed subjects (27 +/- 13 vs. 25 +/- 15%, P = 0.9).